Interestingly, prior studies have shown an association between the IgA isotype of rheumatoid factor (RF) with more severe, erosive disease in RA patients and increased concentrations of the IgA RF predict a poorer clinical response to TNFα inhibitors 33–35. This evidence concerns the gene CD79A and rheumatoid arthritis.